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Summary
Ca2+ as a signaling molecule carries information piv-
otal to cell life and death via its reversible interaction
with a specific site in a protein. Although numerous
Ca2+-dependent activities are known, the proteins
responsible for some of these activities remain un-
identified. We synthesized and characterized a photo-
reactive reagent, azido ruthenium (AzRu), which
interacts specifically with Ca2+ binding proteins and
strongly inhibits their Ca2+-dependent activities, re-
gardless of their catalytic mechanisms or functional
state as purified proteins, embedded in the membrane
or in intact cells. As expected from a Ca2+ binding pro-
tein-specific reagent, AzRu had no effect on Ca2+-
independent and Mg2+-dependent activities. Az103Ru
covalently bound, and specifically labeled, known
Ca2+ binding proteins. AzRu is a photoreactive re-
agent that provides an approach for identification of
Ca2+ binding proteins, characterization of their bind-
ing sites, and exploration of new Ca2+-dependent
processes.
Introduction
Ca2+ is a ubiquitous intracellular signal carrier responsi-
ble for controlling numerous cellular processes [1, 2].
Changes in cytosolic free calcium concentrations,
[Ca2+]i, have been associated with the regulation of
a wide variety of cellular processes as important and
disparate as cell differentiation, transport, motility,
gene expression, metabolism, cell cycle activities, and
pathogenesis [1].
At rest, [Ca2+]i is about 100 nM, but in response to dif-
ferent signals, this level can rise tow1000 nM. Intracel-
lular [Ca2+] is tightly controlled by an array of channels,
pumps, and exchangers that represent ON and OFF
systems [3]. The ON mechanisms feed Ca2+ into the cy-
toplasm from internal and external sources. Ca2+ is re-
leased from the endoplasmic reticulum (ER)/
sarcoplasmic reticulum (SR) by the inositol-1,4,5-tri-
sphosphate receptors and the ryanodine receptors
*Correspondence: vardasb@bgu.ac.il(RyRs) [4], and from mitochondria by efflux systems
[3]. Ca2+ enters the cell through voltage-dependent
Ca2+ channels [5]. The OFF mechanisms turn calcium
signaling off by rapid removal of Ca2+ from the cyto-
plasm by various pumps [6] and exchangers [7]. The
plasma membrane Ca2+-ATPase and Na+/Ca2+ ex-
changers extrude Ca2+ to the outside, whereas the
SR/ER Ca2+-ATPase pumps Ca2+ to the internal stores.
Ca2+ performs its various tasks through binding to
specific Ca2+ binding proteins, distinguished as Ca2+
buffers, Ca2+ sensors, and Ca2+-activated proteins on
the basis of their functions [1]. The Ca2+ sensors (i.e.,
troponin C, calmodulin) respond to an increase in
[Ca2+]i by activating diverse processes, the Ca2+ buffers
(i.e., calsequestrin, parvalbumin) control free [Ca2+], and
Ca2+-activated proteins (i.e., protein kinase C, Ca2+-
ATPases, calpain, NO synthase) are enzymatically active
only in the presence of Ca2+. Isocitrate-, a-ketogluta-
rate-, and pyruvate dehydrogenases are activated via
different mechanisms in response to an increased mito-
chondrial [Ca2+] [8].
Fundamental to the understanding of normal and ab-
normal calcium signaling is the knowledge of the
proteins involved. Several dozens of Ca2+ binding pro-
teins have been identified, purified, and characterized,
and their functions have been established. However,
as judged by the significant amount of Ca2+-dependent
activities in which the participants are unknown, many
Ca2+ binding proteins are yet unidentified. For example,
mitochondria contain several different systems for
transporting Ca2+: the ruthenium red (RuR)-sensitive
uniporter, Na+-dependent and -independent efflux
mechanisms, and the rapid mode of uptake [9]. None
of the proteins responsible for these activities has
been identified. Thus, an important step in elucidating
calcium-signaling mechanisms involves identifying
new Ca2+ binding proteins in order to discover their cel-
lular localization and function in the cell.
Extensive studies have focused on developing spe-
cific Ca2+ binding reagents for probing changes in
[Ca2+]i during cell function; fewer efforts, however,
have been made to probe Ca2+ binding sites in proteins.
In addition, despite advances in defining Ca2+ binding
proteins, considerable experimental difficulties still re-
main in locating their Ca2+ binding sites [10].
In this study, we synthesized and characterized
a novel, to our knowledge, photoreactive reagent—
azido ruthenium (AzRu)—that interacts specifically
with Ca2+ binding proteins and inhibits their activities.
Radioactive Az103Ru covalently and specifically binds
to Ca2+ binding proteins.
Results
With the aim of identifying new Ca2+ binding proteins
and their Ca2+ binding sites, we synthesized a photo-
reactive reagent, AzRu, containing ruthenium and a pho-
toactivable azido group, which can irreversibly interact
with calcium binding proteins. We chose to synthesize
this reagent since azido is a photoreactive group and
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1170Figure 1. Purification and Characterization
of AzRu
(A) AzRu was synthesized and purified by
using a Sephadex LH-20 column. The absor-
bance at 290 nm (open triangles) represents
AzRu (peak II) and at 390 nm (closed circles)
represents that of another compound eluted
from the column (peak III) with no effect on
Ca2+-dependent activities.
(B) Az103Ru was synthesized and purified in
the same manner as AzRu, showing a similar
elution profile as followed by radioactive
counting (closed circles) or absorbance at
290 nm (open triangles).
(C) UV spectra of AzRu, RuCl3, and NaN3.
(D) IR spectrum of AzRu.ruthenium-containing compounds such as RuR (see
[11]) and Ru360 [12, 13] have been shown to interact
with Ca2+ binding proteins and inhibit their activities.
Synthesis, Purification, and Characterization
of AzRu
AzRu, purified by using a Sephadex LH –20 column
(Figure 1A, peak II), has a maximal absorbance at
290 nm, distinct from that of the precursors NaN3 or
RuCl3 (Figure 1C) and of RuR (data not shown). Com-
pounds corresponding to peak I and peak III (lmax =
390 nm) had weak or no effect, respectively, on Ca2+-
dependent activities and, therefore, were not further
characterized. The infrared spectrum of AzRu showed
the characteristic band corresponding to the asym-
metric azide stretching mode at w2072 cm21 (Figure
1D). Such a high wave number is characteristic of
dinuclear m-N3 complexes rather than the terminal N3
groups [14]. The elemental analyses (for O, Na, Cl,
N, Ru) were performed for several samples. The sam-
ples exhibited identical IR and UV-Vis spectra and
a constant percent ratio of Ru:N of 4.8:1. However,
some amount of NaCl and water are also present,
and their quantity varies depending on purification
conditions and the quantity of moisture absorbed by
the hygroscopic material. Based on the spectral fea-
tures and the elemental analyses, we propose the for-
mula of Ru2N3Cl5(H2O)n, where n = 5–10. Interestingly,
a similar ruthenium azide compound was prepared by
Vrestal et al. in 1960 [15]. It was not isolated and was
characterized by its absorption at 290 nm.
A radioactive Az103Ru was also synthesized and puri-
fied (Figure 1B), and its specific activity was used to es-
timate its concentration. Thus, its absorbance at 290 nm
could be used to determine the molar absorbance coef-
ficient of w15,000 for AzRu. AzRu is soluble in water,
and its activity was preserved for over 6 months.AzRu Interacts Specifically with Ca2+ Binding
Proteins
The specific interaction of AzRu with Ca2+-dependent
proteins was demonstrated by testing its effects on
the activities of a variety of known Ca2+-dependent
and Ca2+-independent proteins as summarized in Table
1. Inhibition by AzRu was observed for various Ca2+-de-
pendent proteins with different catalytic mechanisms.
Inhibition of the SR Calcium Pump,
(Ca2+ + Mg2+)ATPase, by AzRu Is Highly
Enhanced by UV Irradiation
The inhibition of Ca2+ accumulation by AzRu was depen-
dent on AzRu concentration (Figures 2A and 2C) and on
time of incubation with or without UV irradiation (Figure
2B). When SR membranes were exposed for 2 min to
UV in the presence of AzRu, Ca2+ accumulation was in-
hibited with a half-maximal inhibition (IC50) of about
1 mM, while, without UV, the IC50 was 4 mM AzRu (Figure
2A). However, increasing the UV exposure time to over 2
min enhanced the AzRu inhibition of the SR Ca2+ accu-
mulation (Figure 2B). Moreover, UV irradiation for 20
min decreased the IC50 for AzRu inhibition of Ca
2+ accu-
mulation by about 140-fold to 7 nM (Figure 2C), suggest-
ing photoactivation and irreversible binding of AzRu to
the protein. The photochemical mechanism probably in-
volves ejection of N2 and unmasking of a highly reactive
nitrene species, as described before [16]. UV irradiation
of the SR membranes had no effect on the control activity
or on the inhibition by AzRu added to the irradiated mem-
branes in the dark (data not shown). In contrast to AzRu
inhibition of SR Ca2+ accumulation, RuR and Ru360 had
no inhibitory effect, but rather, stimulated accumulation
(Figure 2A and Table 2). The difference between the ef-
fects of Ru360 and AzRu on the net Ca2+ accumulation
is due to the different sensitivity of the Ca2+-ATPase to
the two reagents. Ru360 had no effect on Ca2+ accumu-
lation by the SR (Figure 2A). On the other hand, Ru360
(2–4 mM) inhibited ryanodine binding to the SR Ca2+
Photoactivable Reagent for Ca2+-Dependent Proteins
1171release channel (Figure 2D); thus, Ca2+ release was
inhibited and the net accumulation of Ca2+ was thereby
increased. AzRu inhibited both activities at the same
concentration range (Figure 2).
As proposed [17], the stimulatory effect of RuR on
Ca2+ accumulation may result from inhibiting Ca2+ re-
lease mediated by the Ca2+ release channel/ryanodine
receptor (RyR), and thus suggests that at the concentra-
tions used, RuR and Ru360 had no effect on the (Ca2+/
Mg2+)ATPase activity.
Inhibition by AzRu of Ryanodine Binding
to SR RyR
RyR, known as the intracellular Ca2+ release channel,
possesses regulatory Ca2+ binding sites that are
Table 1. AzRu Specifically Inhibits Ca2+-Dependent Activities
Activity (% of Control)
Activity Assayed
AzRu
(20 mM)
AzRu
(100 mM)
Divalent Cation
Involved
1. Ca2+ uptake in
SR (SERCA)
13 6 6 Ca2+
2. Ca2+ uptake in
mitochondria
11 6 4
3. Ryanodine
binding by SR RyR
18 6 6
4. VDAC
conductance
19 6 5
5. Peroxidase 39 6 4
6. CaMKII-
dependent GAPDH
6 6 2
7. Ca2+-dependent
mitochondrial
swellinga
0
8. Yeast hexokinase 77 6 5 64 6 4 Mg2+
9. Brain hexokinase 73 6 7 61 6 3
10. Pyruvate kinase 97 6 7 81 6 6
11. Luciferase 97 6 1 67 6 3
12. (Na+/K+)ATPase 92 6 5 71 6 4
13. K+ channel
(KCNK0)
100 6 0.3 Zn2+
14. Glutamate
dehydrogenaseb
101 6 5 None
15. Lactate
dehydrogenase
91 6 4
16. G-6-P
dehydrogenase
101 6 7
17. GA3P
dehydrogenase
102 6 5
18. Alkaline
phosphatase
86 6 5
19. Succinate-
cytochrome c
oxido-reductase
95 6 5
20. Lysozyme 101 6 3
21. Aldolase 78 6 7
22. Catalase 118 6 8
23. Choline oxidase 85 6 3
Summary of the effects of AzRu on different activities representing
Ca2+-, Mg2+-, or Zn2+-dependent or -independent proteins. Protein
activity was assayed, in the dark, in the absence and the presence
of different concentrations of AzRu as described in Experimental
Procedures, and the degree of inhibition by 20 or 100 mM AzRu is
presented. The results are the mean 6 SEM of 3–6 experiments.
a PTP opening was completely inhibited at this concentration of
AzRu (see Figure 3B).
b The enzyme possesses Ca2+ binding site(s) that are not involved in
its activity.required for binding of the toxic alkaloid ryanodine,
and this binding is inhibited by RuR [4]. AzRu strongly
inhibited the Ca2+-dependent specific binding of
[3H]ryanodine to its receptor in SR (Figure 2D). With no
photoactivation, half-maximal inhibition was obtained
at about 2 mM, and 80% inhibition was obtained at
20 mM AzRu (Figure 2D). At 2 mM, Ru360 had no effect
on ryanodine binding, and at 20 mM, it inhibited binding
partially (35%).
Inhibition of Ca2+ Accumulation in Mitochondria
The mitochondrial electron transfer from succinate to
cytochrome c was not affected by AzRu, although it
involves several electron transfer complexes containing
dozens of polypeptides (Figure 3A). On the other hand,
Ca2+ transport, which is carried out by a yet unidentified
uniporter protein requiring that membrane potential be
established by the electron transport chain, was
strongly inhibited by AzRu, indicating the specificity of
this reagent for Ca2+ binding proteins.
The opening of the permeability transition pore (PTP)
in energized mitochondria, as induced by mitochondrial
Ca2+ overload and monitored by mitochondrial swelling,
was completely prevented by AzRu (Figure 3B). Inhibi-
tion of PTP opening by AzRu was also obtained when
it was added after Ca2+ accumulation had reached
a maximal level (Figure 3C); this suggests that AzRu in-
teracts not only with the Ca2+ uniporter, but also with a
component of the PTP, such as the voltage-dependent
anion channel (VDAC) [18].
AzRu-Induced VDAC Channel Closure
VDAC is a channel protein that possesses Ca2+ binding
sites and transports Ca2+ across the mitochondrial out-
er membrane [11]. Channel activity of purified VDAC re-
constituted into a planar lipid bilayer was measured by
the ions passing current across the bilayer in response
to a voltage gradient of 210 mV, as a function of time
(Figure 3E). In the absence of AzRu, VDAC is stable in
a long-lived, fully opened state and remains open for
up to 2 hr of recording. However, addition of AzRu to
the same channel induced VDAC closure in a time-
dependent manner (Figure 3E). Ca2+, in the presence
of 1 M NaCl, prevented the inhibitory effect of AzRu on
VDAC activity. As has been shown for RuR [11], chela-
tion of Ca2+ with EGTA reestablished AzRu inhibition,
suggesting specific interaction of AzRu with VDAC
Ca2+ binding sites. AzRu also decreased VDAC conduc-
tance in multichannel experiments at all voltages tested
and stabilized VDAC conductance at a constant low
level regardless of the voltage gradient applied (Figure
3D). Similar results have been obtained with RuR and
Ru360 [18].
Inhibition by AzRu of CaM Kinase IIbM-Dependent
GAPDH Activity
The muscle-specific CaM kinase IIbM stimulates the ac-
tivity of GAPDH by 3- to 4-fold in a Ca2+/calmodulin-
dependent manner [19]. AzRu inhibited the activity of
CaM kinase IIbM-dependent GAPDH activity, with 50%
inhibition occurring at 5 mM AzRu and complete inhibi-
tion occurring at 20 mM AzRu. AzRu had no effect on
the activity of the enzyme in a Ca2+/calmodulin-free me-
dium (Table 1), suggesting that inhibition occurs via in-
teraction with calmodulin. Horseradish peroxidase,
a Ca2+ binding protein [20], was also inhibited by AzRu
(Table 1).
Chemistry & Biology
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Ryanodine Binding in Isolated SR: Evidence
for Photoactivation
(A) SR was incubated for 10 min at 24ºC with
the indicated concentration of Ru360 (open
squares) or AzRu (open circles), with (open
circles and squares) or without (closed
circles and squares) 2 min of UV irradiation.
(B) SR was incubated with 1 mM AzRu for the
indicated time, with (open circles) or without
(closed circles) UV irradiation.
(C) SR was incubated for 20 min with the
indicated concentration of AzRu with (open
circles) or without (closed circles) UV irradia-
tion. Samples from (A), (B), and (C) were
assayed for Ca2+ accumulation. Control ac-
tivities (100%) were: 2.4, 2.5, and 2.1 mmol/
mg protein/min for (A), (B), and (C), respec-
tively. The samples that were not exposed
to UV were kept in the dark during all experi-
ments, and those exposed to UV were stirred
during the incubation time.
(D) [3H]Ryanodine binding to SR was as-
sayed following 10 min of incubation in the
dark of SR (1 mg/ml) with the indicated con-
centration of AzRu (closed circles) or Ru360
(open circles). Control activity (100%) = 3.0
pmol ryanodine bound/mg of protein. The
results are a representative experiment of
3–4 similar experiments with different re-
agent and SR preparations.Ca2+-Independent Reactions Are Not Affected
by AzRu
The results, summarized in Table 1, indicate that the ac-
tivities of 16 different Ca2+-independent proteins, such
as glucose-6-phosphate dehydrogenase, lactate dehy-
drogenase, alkaline phosphatase, GAPDH, aldolase,
catalase, lysozyme, choline oxidase, and over two
dozen polypeptides involved in electron transfer in mi-
tochondria, were not or were only slightly inhibited by
AzRu (<10% at 100 mM). In contrast, the activities of
calcium-dependent proteins were strongly inhibited by
AzRu (>90% at % 20 mM). The results also indicate
that the activities of Mg2+-dependent proteins, such as
yeast and brain hexokinase, pyruvate kinase, luciferase,
and (Na+/K+)ATPase, as well as that of the Zn2+-sensitive
KCNK0 channel, were not affected or were weakly in-
hibited at high AzRu concentrations (w30% at 100
mM). These results strongly support the specific interac-
tion of AzRu with Ca2+ binding proteins.Az103Ru Specifically Labeled Ca2+ Binding Proteins
Next, we synthesized radiolabeled Az103Ru and em-
ployed it as a photoaffinity label for Ca2+ binding pro-
teins in SR and mitochondria (Figure 4). UV irradiation
of SR or mitochondria in the presence of Az103Ru re-
sulted in its covalent binding to several proteins, as re-
vealed by SDS-PAGE followed by Coomassie staining
and autoradiography. As expected for the photoreac-
tive Az103Ru, the labeling of the proteins was signif-
icantly increased upon UV irradiation, indicating the
formation of a stable covalent bond. In skeletal muscle
SR incubated with 0.5–2 nmol Az103Ru/mg protein
(0.5–2 mM) with UV irradiation, 10 out of about 30
proteins stained by Coomassie were labeled with
Az103Ru. Among the labeled proteins are known Ca2+
binding proteins such as RyR, myosin, Ca2+-ATPase,
and calsequestrin, but there were also two unidentified
proteins of 29 and 25 kDa (Figure 4A). Similarly, in an
isolated mitochondrial membranal fraction from whichTable 2. Comparison of RuR, Ru360, and AzRu Sensitivity of Different Ca2+-Dependent Activities
IC50, mM
Assay RuR Ru360 AzRua
Ca2+ accumulation in SR No inhibitionb No inhibitionb 4.91 6 0.055
Ca2+ accumulation in mitochondria 0.16 6 0.03 0.067 6 0.008 1.78 6 0.12
Ryanodine binding in SR 7.2 6 0.55 14.8 6 2.8 2.9 6 0.17
Ca2+ accumulation in SR and mitochondria was assayed as described in Experimental Procedures in the absence and presence of different
concentrations of RuR (0.05–100 mM), Ru360 (0.01–100 mM), or AzRu (0.1–100 mM). The concentration required for 50% inhibition (IC50) was de-
rived from the plot of Ca2+ accumulation activity or ryanodine binding as a function of the reagent concentration. The results are the mean 6
SEM of 3–5 experiments.
a Inhibition by photoactivated AzRu is not present in (see Figures 2A and 2C).
b No inhibition; rather, stimulation was obtained.
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1173Figure 3. Ca2+ Uptake, but Not Electron
Transport, Is Inhibited by AzRu in Isolated
Mitochondria
(A) Electron transport (ET) from succinate to
cytochrome c (closed circles) and Ca2+ ac-
cumulation (open circles) were assayed after
10 min of incubation of the mitochondria in
the dark at 24ºC with the indicated concen-
tration of AzRu. Control activities (100%)
were 134 nmol/mg protein and 130 nmol/
mg protein for Ca2+ accumulation and ET, re-
spectively.
(B) Ca2+-induced mitochondrial swelling was
assayed in the absence or in the presence of
10 or 20 mM AzRu. Swelling was initiated by
the addition of Ca2+ (200 mM) to the sample
and was monitored by following the change
in absorbance at 520 nm.
(C) Mitochondria were exposed to Ca2+ ac-
cumulation conditions, and their Ca2+ con-
tent was assayed at the indicated times.
AzRu (20 mM) was added 1 min after Ca2+ ac-
cumulation was initiated and had reached
a maximal level (indicated by the arrow).
(D) Multichannel recordings of the average
steady-state conductance of VDAC before
(closed circles) and 15 min after (open circles)
the addition of 20 mM AzRu as a function of
voltage are shown. Relative conductance
was determined as the ratio of conductance
at a given voltage (G) and the maximal con-
ductance (Go). The experiments are repre-
sentative of 4–5 similar experiments.
(E) AzRu inhibits VDAC channel activity in the
absence, but not in the presence, of Ca2+.
VDAC was reconstituted into a PLB, and
channel currents through VDAC, in response
to a voltage step from 0 to 210 mV, were
recorded before and 10 or 15 min after the ad-
dition of AzRu (20 mM). Where indicated,
VDAC was exposed to 20 mM AzRu in the
presence of 5 mM CaCl2, and recordings were
made at the indicated time or 2 min after
the addition of the indicated compounds. Re-
cordings were also made 5 min after the addi-
tion of EGTA to a final concentration of 6 mM.
The dashed lines indicate zero current.soluble proteins were extracted, photoactivated
Az103Ru labeled 7 out of about 27 proteins stained by
Coomassie (Figure 4B). Weak Az103Ru labeling of the
proteins was observed with no UV irradiation, indicating
a very stable interaction. This finding is not surprising
when considering the reported labeling of mitochondrial
proteins with the nonphotoreactive reagent 103Ru360
[13]. Photoactivated Az103Ru labeled in a concentration-
dependent manner purified calsequestrin and calmodu-
lin, known Ca2+ binding proteins (Figure 4C). Moreover,
purified VDAC was labeled with Az103Ru, and this label-
ing was strongly reduced by preincubation of VDAC
with 1 mM CaCl2 or 100 mM Ru360, indicating the spec-
ificity of AzRu for VDAC Ca2+ binding sites (Figure 4D).
AzRu Protects against Apoptosis Induced
by Staurosporine or by Overexpression of Native
VDAC, but Not E72Q-Mutated VDAC
RuR has been shown to protect against apoptotic cell
death induced by various stimuli in different cell types
(see [21]). Recently, we demonstrated that this RuRprotection against cell death is a result of RuR interac-
tion with VDAC, since it was not observed in E72Q-
mutated VDAC [21]. Exposure of U-937 cells to
staurosporine (STS) for 5 or 7 hr resulted in apoptotic
cell death of about 42% and 76% of the cells, respec-
tively, whereas only 6% of the STS nonexposed cells
died. AzRu, added 18 hr before exposure to STS, dra-
matically reduced STS-activated apoptotic cell death
by about 75% and 47% in cells exposed to STS for 5
and 7 hr, respectively. AzRu had no effect on the viabil-
ity of the cells that were not exposed to STS (Figures 5A
and 5B).
To further investigate the relationship between the
protective effect of AzRu and its interaction with VDAC,
U-937 cells were transfected with native mVDAC or
E72Q-mutated mVDAC1, and the effect of AzRu on apo-
ptotic cell death was examined. As shown previously
[21], transfecting cells with native or E72Q-mutated
mVDAC1 resulted in apoptotic cell death (75%-80%),
as characterized by enhanced nuclear fragmentation.
In contrast, untransfected cells showed 5%–8% cell
Chemistry & Biology
1174Figure 4. Az103Ru Labels SR and Mitochon-
drial Proteins
(A–C) (A) SR, (B) Na2CO3-extracted mito-
chondrial membranes, or (C) purified cal-
modulin or calsequestrin were incubated
for 4 min in the dark (2UV) or were irradiated
with UV in the presence of 0.5 mM or the in-
dicated concentration of Az103Ru and sub-
jected to SDS-PAGE, Coomassie staining
(CBB), and autoradiography. RyR, RyR
monomer; CS, calsequestrin; HMC, heavy
myosin chain; ATPase, Ca2+-ATPase. The
molecular weight standards are presented,
and the Az103Ru-labeled proteins are indi-
cated by arrowheads.
(D) Purified VDAC was irradiated for 4 min
with UV in the presence of 0.5 mM Az103Ru.
Where indicated, VDAC was preincubated
with 1 mM CaCl2 or 100 mM Ru360 before
the labeling with Az103Ru.death (Figure 5C). Preincubation of cells transfected with
native mVDAC1 with 10 mM AzRu for 18 hr dramatically
reduced their apoptotic cell death (71%–84% protec-
tion), while, in cells transfected with E72Q-mutated
mVDAC, AzRu reduced apoptotic cell death by only
31%–34%. AzRu had no effect, nor did it even slightly in-
crease apoptotic death in control cells. Thus, the results
suggest that AzRu protection against apoptosis may be
exerted through its direct interaction with VDAC.
Discussion
AzRu was synthesized in order to develop a photo-
reactive probe specific for Ca2+ binding proteins that
could irreversibly interact with these proteins. Indeed,
the results presented here show that the reagent fulfills
the expected properties and suggest that AzRu can be
of major interest in a wide range of biological studies.
This includes identification of Ca2+ binding sites, and
of new Ca2+ binding proteins and their functions, and
discovering the involvement of Ca2+ in various biologi-
cal phenomena. AzRu exerted its inhibitory effect on
Ca2+-dependent activities regardless of their catalytic
mechanisms or of the functional state of the protein—
purified, embedded in SR or mitochondrial membrane,
or in intact cells.
Specificity of AzRu for Ca2+ Binding Proteins
The specific interaction of AzRu with Ca2+ binding pro-
teins is reflected in the inhibition of their activities. Some
of these proteins catalyze the transport of Ca2+ across
the membrane by distinct mechanisms, all of whichinvolve Ca2+ binding to the protein. Some examples
are the Ca2+ pump that transports Ca2+ at the expense
of ATP hydrolysis (Figures 2A–2C), the uniporter at the
mitochondrial inner membrane that transports Ca2+ to
the matrix and is driven by the membrane potential (Fig-
ure 3A), and the outer mitochondrial channel VDAC,
which transports and binds Ca2+ [11] (Figures 3D and
3E). The reagent also interacted with regulatory Ca2+
binding sites, such as those of calmodulin and RyR
(Table 1 and Figure 2D).
AzRu had no effect on Ca2+-independent reactions
and only slightly affected Mg2+-dependent activities
(Table 1), indicating the specificity of AzRu for Ca2+
binding proteins. The interaction of AzRu with Ca2+
binding sites is further supported by the results showing
that the inhibition of VDAC channel activity by AzRu was
prevented in the presence of Ca2+ and was reestab-
lished upon Ca2+ removal (Figure 3E).
The results obtained with the radioactive Az103Ru fur-
ther support its specificity for Ca2+ binding proteins.
Upon photoactivation, Az103Ru covalently bound to
several SR known Ca2+-dependent proteins such as
Ca2+-ATPase, calsequestrin, and RyR. Mitochondria
contain several Ca2+-activated enzymes in the matrix
[8] and possess Ca2+ influx and efflux activities cata-
lyzed by as yet unidentified proteins [9]. In mitochon-
drial membranes free of soluble proteins, about seven
proteins were labeled with Az103Ru, among them
VDAC [11] and aralar [22], both possessing Ca2+ binding
sites. AzRu binding to VDAC was inhibited in the pres-
ence of Ca2+, indicating the specificity of AzRu for
VDAC Ca2+ binding sites. These results indicate that,
Photoactivable Reagent for Ca2+-Dependent Proteins
1175Figure 5. AzRu Protects against Apoptotic
Cell Death Induced by STS or by Overex-
pression of Native, but Not E72Q-Mutated,
VDAC
(A) U-937 cells were incubated (a and c) with-
out or (b and d) with AzRu (10 mM) for 18 hr
and thereafter were exposed to (c and d)
STS (1.25 mM). After 5 hr, the cells were
stained with acridine orange and ethidium
bromide. Arrows indicate cells in an early
apoptotic state, represented by a degraded
nucleus (stained by acridine orange). Arrow-
heads indicate a late apoptotic state, as
shown by the presence of a degraded nu-
cleus (stained by both acridine orange and
ethidium bromide). Scale bar, 20 mm.
(B) Quantitative analysis of apoptotic cell
death in control cells and cells exposed to
AzRu, RuR, and Ru360 (10 mM) was as-
sessed 5 and 7 hr after their exposure to
STS (1.25 mM) by ANOVA and a Student’s t
test. p < 0.001 was considered statistically
significant (marked by three asterisks). Data
are the means 6 SEM of three independent
experiments. In each independent experi-
ment, approximately 200 cells were counted
for each treatment.
(C) Quantitative analysis of cell death in-
duced by native or E72Q-mutated VDAC1
overexpression. U-937 cells were trans-
fected with a plasmid encoding native or
E72Q-mutated VDAC1. AzRu (10 mM) was
added to the cells 56 hr after transfection,
and, 20 hr later, cell viability was analyzed
by acridine orange/ethidium bromide stain-
ing as described in Experimental Proce-
dures. ANOVA and a Student’s t test were
used, and p < 0.001 (marked by three aster-
isks) and p < 0.01 (marked by two asterisks)
were considered statistically significant. Val-
ues represent the means 6 SEM of three in-
dependent experiments.indeed, the reagent is photoreactive and specifically
binds to Ca2+ binding proteins. Thus, Az103Ru could
be a useful tool for the identification of unidentified
Ca2+ binding proteins, and for probing the location
and possible structure of the Ca2+ binding sites.
Comparison of AzRu, RuR, and Ru360 Effects
The polycationic RuR and Ru360 have been employed
in various studies as inhibitors of Ca2+-dependent reac-
tions (see [11]). In contrast to RuR and Ru360, AzRu
is a photoreactive reagent, as reflected in its UV-
enhanced inhibition, and increased apparent binding
affinity by about 140-fold (Figure 2C). As shown here,
even with no photoactivation, AzRu, in contrast to RuR
and Ru360, was effective in inhibiting the SR Ca2+ pump
(Figure 2A and Table 2). AzRu was also more effective
than RuR or Ru360, with or without photoactivation, in
inhibiting the Ca2+-dependent binding of ryanodine to
RyR (Figure 2D and Table 2). This may open the way
to inhibit other Ca2+-dependent activities that are not
sensitive to RuR, such as the plasma membrane Ca2+-
ATPase.
The binding mechanism of AzRu to Ca2+ binding pro-
teins is not yet defined. However, we assume that the
same proposed mechanism for RuR and Ru360 applies
to AzRu. Recently [23], using site-directed mutagenesis,it has been shown that RuR interconnects glutamate
residues located in two subunits of the TASK-3 potas-
sium channel and that this interaction is required for
its inhibitory action. Thus, the reagent activity is depen-
dent on the reagent charge and on the location of the
charged Ru moiety in the molecule. This may explain
why the cation Ru3+ is not an inhibitor, and may explain
the differential effects of RuR, Ru360, and AzRu in inhib-
iting various Ca2+-dependent activities (see Table 2).
Thus, the mechanism by which ruthenium-containing
compounds interact with Ca2+ binding proteins may in-
volve interaction with several negatively charged resi-
dues located in a specific geometry.
In intact cells, RuR was shown to slowly cross the
plasma membrane and to protect against cell death in-
duced by various stimuli (see [21]). Similar to RuR and
Ru360, AzRu protected against apoptotic cell death in-
duced by STS (Figures 5A and 5B). Moreover, AzRu pro-
tected against apoptotic cell death induced by
overexpression of native mVDAC1, but not E72Q-
mutated mVDAC1 (Figure 5C), suggesting that AzRu is
able to enter into the cell and that its protective effect
is a result of its interaction with VDAC.
RuR was employed to improve mitochondrial produc-
tion in ischemic reperfused pig myocardium [24], was
employed in the nervous system to follow neuronal
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certain conditions [26]. Considering the potent activity
of AzRu in RuR-insensitive reactions (see Table 2), its
applications in various biological studies should be
explored.
AzRu as a Powerful Tool to Assess Ca2+-Dependent
Cellular Processes
An important step toward elucidating Ca2+ signaling
mechanisms and discovering the cellular localization
and functions of the proteins involved is the identifica-
tion of as many Ca2+ binding proteins as possible. To
our knowledge, the photoreactive AzRu, developed in
this study, is a novel affinity labeling reagent that has
a high degree of specificity toward Ca2+ binding pro-
teins and most probably interacts at or around the
Ca2+ binding site of target proteins. Radioactive AzRu
with its covalent binding capacity (Figure 4) can be
used to identify Ca2+ binding proteins, such as the un-
identified mitochondrial uniporter, and the proteins me-
diating Na+-dependent and -independent efflux [9].
To conclude, the results of this study suggest that
AzRu and Ca2+ share their protein binding sites and
that AzRu, as a photoreactive reagent, could be used
as a probe to determine the binding site of Ca2+. This
new, to our knowledge, reagent can be exploited in de-
veloping a novel methodological approach for the iden-
tification of new Ca2+ binding proteins and their Ca2+
binding sites, and in uncovering their functions.
Significance
To our knowledge, the present work reports the syn-
thesis, characterization, and applications of the first
photoreactive Ca2+ analog reagent, AzRu, that binds
covalently to Ca2+ binding sites in proteins. The ubiq-
uitous and pivotal role of Ca2+ in diverse physiological
processes is evident. Ca2+ acts as a messenger, stim-
ulating numerous processes vital to cell life and
death. However, despite advances in defining Ca2+-
dependent activities, difficulties in detecting Ca2+
binding proteins still remain. The specificity of AzRu
for Ca2+ binding proteins, its photoactivation, and its
radioactive labeling pave the way for the wide use of
AzRu as a powerful tool to assess Ca2+-dependent cel-
lular processes, both in vitro and in vivo. The reagent
has a number of intriguing fundamental properties
that may open new avenues to address various Ca2+-
dependent biological phenomena, among them
protein-protein interactions. Indeed, novel AzRu-
based optical biosensor chips are currently under de-
velopment and will be used to search for new Ca2+
binding proteins and for the identification of specific
protein complexes, by using a chip containing Ca2+
binding proteins. Thesewould allow for the generation
of a comprehensive Ca2+-targeted protein database
and detection of defective Ca2+ binding proteins in-
volved in various diseases and disorders, potentially
leading to identification of novel biomarkers for dis-
ease diagnostics. Furthermore, developing fluores-
cent AzRu derivatives as probes for the application
of Ca2+ binding protein imaging in living cells (in prog-
ress) would allow us to follow Ca2+ binding protein
distribution under specific conditions.Experimental Procedures
Materials
Aldolase, alkaline phosphatase, ATP, bovine liver catalase, choline
oxidase, CM-cellulose, n-decane, glucose 6-phosphate dehydroge-
nase, glutamate dehydrogenase, glyceraldehyde 3-phosphate de-
hydrogenase, HEPES, yeast hexokinase, lactate dehydrogenase,
leupeptin, luciferase, mannitol, horseradish peroxidase, PMSF, py-
ruvate kinase, soybean asolectin, sucrose, Tris, and Triton X-100
were purchased from Sigma (St. Louis, MO, USA). [45Ca], [103Ru],
and [3H]ryanodine were purchased from NEN Life Science Products,
Inc. (Boston, USA). Unlabeled ryanodine was obtained from Calbio-
chem. Sephadex LH-20 was purchased from Amersham Bioscien-
ces. n-Octyl-b-D-glucopyranoside (b-OG) was obtained from
Bachem AG (Germany). Lauryl-(dimethyl)-amineoxide (LDAO) and
ruthenium red (98% pure) were obtained from Fluka (Chemie,
GmbH). Ruthenium chloride was purchased from Aldrich. Hydroxy-
apatite (Bio-Gel HTP) was purchased from Bio-Rad Laboratories
(Hercules, CA), and Celite was purchased from Merck. Synthetic
firefly D-luciferin reagent was purchased from Biosynth AG. Ru360
was synthesized according to Ying et al. [12].
UV-Vis spectra were recorded by an Ultraspec 2100 spectropho-
tometer, and IR spectra were recorded by a Nicolet 5ZDX
instrument.
Synthesis, Purification, and Characterization of AzRu
RuCl3$3H2O (150 mg) was dissolved in 1.44 ml 6 N HCl, and 0.2 ml
absolute ethanol was added. The solution was placed in a water
bath at 95ºC in order to reduce any Ru (IV) normally present in com-
mercial RuCl3$3H2O. After 1 hr, NaN3 (93.6 mg) and water were
added, giving a final volume of 10 ml, and the solution was incu-
bated for 4 hr at 95ºC in a sealed tube. The reaction solution was
then loaded into a Sephadex LH-20 column (3 3 70 cm) previously
equilibrated with water. The column was washed with water, and the
fractions (3 ml) with maximal absorption at 290 nm (peak II) were
combined and lyophilized to dryness. The product was then ana-
lyzed by TLC by using cellulose F plates and 0.16 M ammonium for-
mate (pH 8.5) and 20% methanol as a developer. The peak II product
migrated as a single spot with Rf = 0.9, distinct from the mobility of
RuCl3 (Rf = 0) and NaN3 (Rf = 0.77). The purified product, azido-
ruthenium, has a maximal absorbance at 290 nm and a molar co-
efficient of w15,000. The elemental analyses of different samples
invariably showed a 4.8:1 molar ratio of Ru:N, corresponding to
that of Ru2N3. However, some amount of NaCl was always present
in the samples, and the content of Cl and water varied correspond-
ing to the empirical formulas from Ru2N3Cl53 (nH2O, mNaCl) where
n = 5–10, m = 2–3 (the analyses for Ru, N, Cl, Na, and O were carried
out by SGS Cervac Wolff, Service Analyses Elementaires, Evry,
France).
Attempts to obtain AzRu crystals from a solution of methanol, eth-
anol, acetonitrile, diethyl ether, or their different combinations re-
sulted in a hygroscopic powder or microcrystals that was not
suitable for X-ray structure determination.
The radiolabeled AzRu was synthesized as described above for
the nonradioactive reagent, by using 4.5 mg RuCl3 (23.5 mmol) and
1 mCi 103Ru. All additions were proportionately reduced at a final vol-
ume of 1.2 ml. The Sephadex LH-20 column dimensions were 1.5 3
40 cm. The yield of the synthesis was 5.4 mmol AzRu (about 44% of
the Ru3+ used), with a specific activity of 200 cpm/pmol AzRu.
Membrane and Protein Preparations
SR membranes were prepared from rabbit fast twitch skeletal mus-
cle as described by Saito et al. [27]. Mitochondria were isolated from
rat liver as described previously [11]. Na2CO3-extracted mitochon-
drial membranes were obtained by incubation of rat liver mitochon-
dria (5 mg/ml) with 50 mM Na2CO3 (pH 11) for 30 min at 4ºC, and the
pellet obtained by centrifugation at 20,000 3 g for 20 min was
washed twice with 10 mM Tricine (pH 7.4). Protein concentration
was determined according to Lowry [28].
Ca2+ Accumulation by SR or Mitochondrial Membranes
Mitochondrial 45Ca2+ uptake by freshly isolated mitochondria
(0.5 mg/ml) was assayed for 0.5–7 min at 30ºC in the presence of
225 mM mannitol, 75 mM sucrose, 120 mM CaCl2 (containing 3 3
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1177104 cpm/nmol 45Ca2+), 5 mM HEPES/KOH, 5 mM succinate, and 0.l
mM Pi (pH 7.0) [11]. SR membranes (0.04 mg/ml) were incubated for
2–20 min with AzRu (10 nM to 5 mM) in the dark or were irradiated
with a 15 W ultraviolet lamp in 20 mM Mops, 0.1 M KCl (pH, 6.8).
45Ca2+ uptake by the SR was assayed for 2 min in the presence of
20 mM Mops, 0.1 M KCl, 1.5 mM MgCl2, 1.5 mM ATP, 0.5 mM
EGTA, 0.5 mM CaCl2 (containing 3 3 10
4 cpm/nmol 45Ca2+), and
50 mM Pi (pH 6.8) as described previously [29]. 45Ca2+ uptake was
terminated by rapid Millipore filtration followed by a wash with 5
ml of 150 mM KCl.
Mitochondrial Swelling
Ca2+-induced mitochondrial swelling was assayed in freshly iso-
lated mitochondria under the same conditions as those employed
for Ca2+ accumulation, except that the reaction was performed at
24ºC. Swelling was initiated by the addition of Ca2+ (0.2 mM) to
the sample cuvette. Absorbance changes at 520 nm were monitored
every 15–20 s with an Ultraspec 2100 spectrophotometer.
[3H]Ryanodine Binding
Ryanodine binding by SR membranes was assayed as described
previously [10]. Membranes were incubated for 60 min at 37ºC in
a standard binding solution containing 1 M NaCl, 20 mM Mops
(pH 7.4), 50 mM free [Ca2+], and 20 nM [3H]ryanodine, followed by
vacuum filtration of the sample through nitrocellulose filters (0.3
mm). Specific binding of [3H]ryanodine was defined as the difference
between the binding in the absence and the presence of 100 mM un-
labeled ryanodine.
Protein Purifications
The voltage-dependent anion channel (VDAC) was extracted from
mitochondria with 2% LDAO and was purified by using LDAO and
a hydroxyapatite/Celite column followed by a carboxymethyl
(CM)-cellulose column in which LDAO was replaced by 0.3%
b-OG [18]. Rat brain hexokinase-I (HK-I) [30], sheep brain calmodu-
lin [31], and egg lysozyme [32] were purified as described.
VDAC Channel Recording and Analysis
Reconstitution of the purified VDAC into a planar lipid bilayer (PLB),
multichannel current recording, and data analyses were carried out
as previously described [11]. Purified VDAC was added to the cham-
ber defined as the cis side. Currents were recorded under voltage-
clamp mode by using a Bilayer Clamp BC-525B amplifier and were
measured with respect to the trans side of the membrane (ground).
Photoaffinity Labeling with Az103Ru
SR, mitochondria, or purified proteins were irradiated with a 15 W
ultraviolet lamp for 3–4 min in the presence of 100 nM-1 mM
Az103Ru (200 cpm/pmol) in 40 ml of 20 mM Tricine (pH 7.4). The irra-
diated samples were subjected to SDS-PAGE [33], followed by Coo-
massie staining, and the dried gel was exposed directly to Kodak
X-Omat film (Eastman Kodak Co.).
Potassium Channel Activity
Xenopus laveis oocytes were isolated and injected with 23 nl con-
taining 0.2 ng cRNA KCNK0 as described [34]. Whole-cell currents
were measured 2 days after injection by a two electrode voltage
clamp (Axon Instruments, Union City, CA, USA). Data were filtered
at 0.5 kHz and sampled at 2 kHz. The bath solution contained (in
mM): 4 KCl, 96 NaCl, 1 MgCl2, 0.3 CaCl2, 5 HEPES/NaOH (pH 7.5).
Oocytes were held at 280 mV, and currents were monitored every
5 s for 100 ms at +20 mV.
Tissue Culture and Induction of Apoptotic Cell Death
The U-937 human monocytic cell line was grown under an atmo-
sphere of 95% air and 5% CO2 in RPMI 1640 supplemented with
10% fetal calf serum (FCS), 1 mM L-glutamine, 100 U/ml penicillin,
and 100 mg/ml streptomycin. Cells were plated at a density of
5.4 3 104 cells/cm2 in 24-well plates and were then incubated with
or without AzRu for 18 hr before exposure to 1.25 mM staurosporine
(STS) to induce apoptosis. Cell viability was analyzed 5 and 7 hr af-
ter STS addition by staining with 100 mg/ml acridine orange (AcOr)
and 100 mg/ml ethidium bromide (EtBr) in PBS [21]. The cells were
then visualized by fluorescence microscopy (Olympus IX51), andimages were recorded on an Olympus DP70 camera, with an SWB
filter. For cell transfection, logarithmically growing U-937 cells
were resuspended in RPMI 1640 supplemented with 10% FCS,
100 U/ml penicillin, and 100 mg/ml streptomycin at a concentration
of 2.5 3 107 cells/ml and were transfected with pEGFP-mVDAC1
or pEGFP-E72Q-mVDAC1. Transfection was performed by electro-
poration with a single pulse from a Bio-Rad micropulser II with a ca-
pacitance extender unit (200 V, 950 mF). Cells were incubated on ice
for 10 min before and after transfection, and then resuspended in 20
ml RPMI 1640 supplemented with 10% FCS, 1 mM l-glutamine, 100
U/ml penicillin, and 100 mg/ml streptomycin. Transfection efficien-
cies were 68%–72%, as assessed by GFP expression. GFP-positive
cells were viewed under a fluorescence microscope (Olympus IX51)
with a blue filter.
Enzymatic Activities
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), aldolase,
lactate dehydrogenase, pyruvate kinase [19], rat brain hexoki-
nase-I, yeast hexokinase [30], glucose 6-phosphate dehydroge-
nase, and glutamate dehydrogenase activities were carried out at
room temperature by monitoring spectrophotometrically the reduc-
tion of NAD+ or the oxidation of NADH at 340 nm by using an Ultra-
spec 2100 spectrophotometer.
Alkaline phosphatase activity was assayed by using p-nitrophenyl
phosphate as a substrate, and the formation of p-nitrophenol was
monitored spectrophotometrically at 410 nm as previously de-
scribed [35].
Lysozyme activity was assayed as described previously [36], with
slight modification. Lysozyme was added to 1 ml of a suspension of
M. lysodeikticus cells in a 0.2 M phosphate buffer (pH 6.2) at room
temperature. The decrease in the absorbance at 540 nm was mon-
itored for 1 min.
Luciferase activity was measured by using luciferin as a substrate
[37]. Briefly, samples were incubated in 4 mM Mg-HEPES, Na-EDTA,
1 mg/ml BSA, 0.1 mM D-luciferin, w20 mg/ml firefly luciferase, 20
mM K-HEPES (pH 7.8), and 50 nM ATP. The chemiluminescent
product was detected by using a BioOrbit 1251 luminometer.
Bovine liver catalase activity was measured spectrophotometri-
cally at room temperature by monitoring the changes in H2O2 absor-
bance at 240 nm as described previously [38]. The reaction was
started by the addition of H2O2 to a final concentration of 10 mM.
Horseradish peroxidase (HRP) and choline oxidase activities were
measured as described previously [39]. Samples were incubated in
250 mM NaCl, 2 mM MgCl2, 5 mM Tris (pH 8.5), 0.1 mM homovanillic
acid, 6 U/ml horseradish peroxidase, and 2.5 U/ml choline oxidase.
Fluorescence measurements were carried out by using a Perking El-
mer LS 55 fluorometer.
Succinate-cytochrome c oxido-reductase activity was measured
in isolated mitochondria as described before [11].
(Na+/K+)ATPase activity of brain protein membranal fraction
(0.1 mg/ml) was assayed following incubation for 10 min at 30ºC
in a solution containing 2 mM [g-32P]ATP (104 cpm/mmol), 2 mM
MgCl2, 25 mM imidazole (pH 7.5), 10 mM KCl, 100 mM NaCl, and
0.5 mM Tris-EGTA. The [32P]Pi released from [g-
32P]ATP was ana-
lyzed according to Avron [40], and the radioactivity was measured
in a liquid scintillation counter.
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